Affordable Access

Early versus periprocedural administration of abciximab for primary angioplasty : a pooled analysis of 6 studies

Publication Date


The 2004 ACC/AHA guidelines on ST-elevation myocardial infarction state that it is reasonable to start treatment with abciximab as early as possible before primary percutaneous coronary intervention (PCI). We investigated the potential benefit of early use of abciximab by pooling data from all the available studies.

There are no comments yet on this publication. Be the first to share your thoughts.